Resmed Inc (RMD)

$256.96 +1.08 (0.42%)
Market Cap 37.68B
Revenue (ttm) 4.69B
Net Income (ttm) 1.02B
EPS (ttm) N/A
PE Ratio 28.18
Forward PE 24.54
Profit Margin 21.79%
Debt to Equity Ratio 0.12
Volume 391,800
Avg Vol 899,962
Day's Range N/A - N/A
Shares Out 146.63M
Stochastic %K 65%
Beta 0.77
Analysts Sell
Price Target $258.75

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposab...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 858-836-5000
Address:
9001 Spectrum Center Boulevard, San Diego, United States
Prime_Time_Trader
Prime_Time_Trader Jul. 2 at 12:12 PM
$VVOS $RMD With FDA approval and Medicare backing, VVOS is either getting bought by these guys or $RMD is in for a hell of a ride down. CPAP machines will be a thing of the past.
1 · Reply
StrawberryRips
StrawberryRips Jun. 30 at 9:21 PM
From Grok: Conclusion Incannex Healthcare Inc. (IXHL) is a plausible buyout/partnership candidate for ResMed Inc. (RMD) due to its strategic fit in the OSA market, existing collaboration, and ResMed’s financial capacity and acquisition history. IXHL’s IHL-42X, if successful in clinical trials, could complement ResMed’s device and software portfolio, enhancing its 2030 strategy to address sleep and breathing health. However, the buyout’s feasibility hinges on IHL-42X’s trial outcomes, IXHL’s valuation, and ResMed’s strategic priorities. While no direct evidence of a buyout exists, the collaboration via Dr. Wimms and market alignment suggest a strong foundation for acquisition interest. $RMD $IXHL
0 · Reply
StrawberryRips
StrawberryRips Jun. 29 at 6:28 PM
$IXHL is about to tap into a $10 Billion dollar market… Company is currently only worth approx $20 Million. FDA phase 2 news due July. Has until October 20 for compliance. Warrants cancelled. Positive and multiple PR’s. Company wants to provide shareholder value. Nobody likes CPAP machines. IHL-42X is an alternative drug, and will likely be the only FDA approved one in the near future. $RMD would be interested here. Also maybe $MRK…
1 · Reply
buythewinners
buythewinners Jun. 29 at 4:03 PM
$IXHL $RMD $F $GM $YHOO Get DD asap
0 · Reply
buythewinners
buythewinners Jun. 29 at 3:42 PM
$IXHL $INM $INMB $RMD $LLY $PFE TOP LINE phase2 results due in July for OSA pill form therapy! FDA approved Phase3 already which is going on in both the US & UK. DON'T MISS THIS ONE!! ROI
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Jun. 28 at 11:10 PM
$RMD Ixhl buy out annoucment in the next 2 weeks ,scoop up some cheap ixhl before the buy and and phase 2 results.
0 · Reply
GetBottomWinners
GetBottomWinners Jun. 28 at 7:27 PM
$IXHL $RMD $LLY $PFE $AAPL One of a kind novel therapy! Pill form for OSA sleep apnea!! P2 TOP LINE results coming in July!! Tick Tock bio investors!!!
0 · Reply
izjustlooking
izjustlooking Jun. 28 at 4:23 PM
$IXHL I recon $RMD will be the ones to scoop up this company
1 · Reply
abc3000
abc3000 Jun. 18 at 1:53 PM
$IXHL Putting a high ranking member from $RMD onto Incannex's board tells me it is all the more likely that $RMD will ultimately swoop down and buy this biotech once the RePOSA Phase 2 data come out in July. 1/8 of the world's adults suffer from sleep apnea, and there is currently NO pharmacologic treatment available. This could be monumental. Plus -- I cannot wait to be one of their first customers. I HATE my sleep apnea!
0 · Reply
abc3000
abc3000 Jun. 18 at 1:24 PM
$IXHL I am going to make a prediction right now: Resmed ($RMD) is going to swoop down and buy this company once the Phase 2 RePOSA data is published.
0 · Reply
Latest News on RMD
Top 15 High-Growth Dividend Stocks For July 2025

Jul 1, 2025, 9:02 PM EDT - 3 days ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Jul 1, 2025, 4:05 PM EDT - 4 days ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 9, 2025, 5:38 AM EDT - 26 days ago

ResMed: A Sleeping Giant Hiding In Plain Sight

Top 15 High-Growth Dividend Stocks For June 2025

Jun 2, 2025, 10:00 AM EDT - 4 weeks ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 15, 2025, 9:00 AM EDT - 7 weeks ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Top 15 High-Growth Dividend Stocks To Consider For May 2025

May 2, 2025, 11:21 AM EDT - 2 months ago

Top 15 High-Growth Dividend Stocks To Consider For May 2025

AMAT APH DKS DPZ GPN INTU LRCX

Resmed Acquires VirtuOx

May 1, 2025, 9:00 AM EDT - 2 months ago

Resmed Acquires VirtuOx

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 24, 2025, 3:24 PM EDT - 2 months ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

ResMed: Cornering The Market In Sleep Solutions

Apr 24, 2025, 5:12 AM EDT - 2 months ago

ResMed: Cornering The Market In Sleep Solutions

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 7:16 PM EDT - 2 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 5:08 PM EDT - 2 months ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 23, 2025, 4:05 PM EDT - 2 months ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 21, 2025, 5:00 PM EDT - 2 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 3, 2025, 9:00 AM EDT - 3 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Apr 2, 2025, 4:05 PM EDT - 3 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

My Top 15 High-Growth Dividend Stocks For April 2025

Apr 2, 2025, 2:12 AM EDT - 3 months ago

My Top 15 High-Growth Dividend Stocks For April 2025

AMAT APH DPZ GPN INTU LRCX MPWR

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 19, 2025, 8:00 AM EDT - 3 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Mar 11, 2025, 9:00 AM EDT - 4 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

My Top 15 High-Growth Dividend Stocks For March 2025

Mar 3, 2025, 4:34 PM EST - 4 months ago

My Top 15 High-Growth Dividend Stocks For March 2025

APH DPZ GPN INTU KLAC LRCX MPWR

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 26, 2025, 3:00 AM EST - 4 months ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 5 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Feb 10, 2025, 10:38 AM EST - 5 months ago

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Stock Of The Day: Trading The Range In ResMed

Feb 3, 2025, 12:59 PM EST - 5 months ago

Stock Of The Day: Trading The Range In ResMed

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 9:10 PM EST - 5 months ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 5:21 PM EST - 5 months ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Jan 30, 2025, 4:05 PM EST - 5 months ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Top 50 High Quality Dividend Growth Stocks - January 2025

Jan 12, 2025, 12:52 PM EST - 6 months ago

Top 50 High Quality Dividend Growth Stocks - January 2025

MA MPWR MSCI QCOM RACE ROL ZTS

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

Jan 9, 2025, 4:05 PM EST - 6 months ago

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:05 PM EST - 6 months ago

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

My Top 15 High Growth Dividend Stocks For January 2025

Jan 2, 2025, 10:49 PM EST - 6 months ago

My Top 15 High Growth Dividend Stocks For January 2025

APH DPZ ELV GPN INTU MA MPWR

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Dec 23, 2024, 2:59 PM EST - 6 months ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

INSP LLY

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

Dec 4, 2024, 4:13 AM EST - 7 months ago

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

My Top 15 High-Growth Dividend Stocks For December 2024

Dec 2, 2024, 6:00 AM EST - 7 months ago

My Top 15 High-Growth Dividend Stocks For December 2024

ACN APH CNI DPZ ELV GPN INTU

ResMed Announces Participation in the UBS Global Healthcare Conference

Nov 5, 2024, 4:05 PM EST - 8 months ago

ResMed Announces Participation in the UBS Global Healthcare Conference

My Top 15 High-Growth Dividend Stocks For November 2024

Nov 3, 2024, 2:44 PM EST - 8 months ago

My Top 15 High-Growth Dividend Stocks For November 2024

ACN APH DPZ ELV GPN INTU LRCX

ResMed CEO On Earnings, Sleep Apnea

Oct 29, 2024, 11:23 AM EDT - 8 months ago

ResMed CEO On Earnings, Sleep Apnea

Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst

Oct 25, 2024, 11:15 AM EDT - 9 months ago

Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

Oct 24, 2024, 11:14 PM EDT - 9 months ago

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices

Oct 24, 2024, 5:00 PM EDT - 9 months ago

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

Oct 3, 2024, 4:05 PM EDT - 9 months ago

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

My Top 15 High Growth Dividend Stocks For October 2024

Oct 3, 2024, 12:04 PM EDT - 9 months ago

My Top 15 High Growth Dividend Stocks For October 2024

ACN APH DPZ ELV GPN INTU MA

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

Sep 30, 2024, 4:05 PM EDT - 9 months ago

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

Sep 30, 2024, 9:48 AM EDT - 9 months ago

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

Sep 30, 2024, 9:23 AM EDT - 9 months ago

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

Sep 30, 2024, 8:10 AM EDT - 9 months ago

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

Sep 30, 2024, 8:01 AM EDT - 9 months ago

ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety

Sep 19, 2024, 12:45 AM EDT - 10 months ago

ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety

S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand

Sep 18, 2024, 5:55 PM EDT - 10 months ago

S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand

Why ResMed's Rally Is Just Getting Started

Sep 18, 2024, 11:30 AM EDT - 10 months ago

Why ResMed's Rally Is Just Getting Started

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

Sep 10, 2024, 4:05 PM EDT - 10 months ago

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

Prime_Time_Trader
Prime_Time_Trader Jul. 2 at 12:12 PM
$VVOS $RMD With FDA approval and Medicare backing, VVOS is either getting bought by these guys or $RMD is in for a hell of a ride down. CPAP machines will be a thing of the past.
1 · Reply
StrawberryRips
StrawberryRips Jun. 30 at 9:21 PM
From Grok: Conclusion Incannex Healthcare Inc. (IXHL) is a plausible buyout/partnership candidate for ResMed Inc. (RMD) due to its strategic fit in the OSA market, existing collaboration, and ResMed’s financial capacity and acquisition history. IXHL’s IHL-42X, if successful in clinical trials, could complement ResMed’s device and software portfolio, enhancing its 2030 strategy to address sleep and breathing health. However, the buyout’s feasibility hinges on IHL-42X’s trial outcomes, IXHL’s valuation, and ResMed’s strategic priorities. While no direct evidence of a buyout exists, the collaboration via Dr. Wimms and market alignment suggest a strong foundation for acquisition interest. $RMD $IXHL
0 · Reply
StrawberryRips
StrawberryRips Jun. 29 at 6:28 PM
$IXHL is about to tap into a $10 Billion dollar market… Company is currently only worth approx $20 Million. FDA phase 2 news due July. Has until October 20 for compliance. Warrants cancelled. Positive and multiple PR’s. Company wants to provide shareholder value. Nobody likes CPAP machines. IHL-42X is an alternative drug, and will likely be the only FDA approved one in the near future. $RMD would be interested here. Also maybe $MRK…
1 · Reply
buythewinners
buythewinners Jun. 29 at 4:03 PM
$IXHL $RMD $F $GM $YHOO Get DD asap
0 · Reply
buythewinners
buythewinners Jun. 29 at 3:42 PM
$IXHL $INM $INMB $RMD $LLY $PFE TOP LINE phase2 results due in July for OSA pill form therapy! FDA approved Phase3 already which is going on in both the US & UK. DON'T MISS THIS ONE!! ROI
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Jun. 28 at 11:10 PM
$RMD Ixhl buy out annoucment in the next 2 weeks ,scoop up some cheap ixhl before the buy and and phase 2 results.
0 · Reply
GetBottomWinners
GetBottomWinners Jun. 28 at 7:27 PM
$IXHL $RMD $LLY $PFE $AAPL One of a kind novel therapy! Pill form for OSA sleep apnea!! P2 TOP LINE results coming in July!! Tick Tock bio investors!!!
0 · Reply
izjustlooking
izjustlooking Jun. 28 at 4:23 PM
$IXHL I recon $RMD will be the ones to scoop up this company
1 · Reply
abc3000
abc3000 Jun. 18 at 1:53 PM
$IXHL Putting a high ranking member from $RMD onto Incannex's board tells me it is all the more likely that $RMD will ultimately swoop down and buy this biotech once the RePOSA Phase 2 data come out in July. 1/8 of the world's adults suffer from sleep apnea, and there is currently NO pharmacologic treatment available. This could be monumental. Plus -- I cannot wait to be one of their first customers. I HATE my sleep apnea!
0 · Reply
abc3000
abc3000 Jun. 18 at 1:24 PM
$IXHL I am going to make a prediction right now: Resmed ($RMD) is going to swoop down and buy this company once the Phase 2 RePOSA data is published.
0 · Reply
TheGiantKiller
TheGiantKiller Jun. 13 at 10:47 PM
$IXHL ResMed's ($RMD) interest in Incannex's IHL-42X for Obstructive Sleep Apnea relates to the possibility of combination therapies between IHL-42X and ResMed CRAP machines. That's the reason ResMed placed one of its scientists on the Incannex Scientific Advisory Board. There's a very good chance ResMed will make an investment in Incannex if the IHL-42X Phase 2 results come in positive.
0 · Reply
MikiTrader
MikiTrader Jun. 10 at 12:56 PM
$IXHL asked AI what I was curious about. I felt a huge flow. It's also important to note that while non-orphan drugs that qualify as New Chemical Entities (NCEs) typically benefit from 5 years of data exclusivity under the Hatch-Waxman Act. Let me explain how I feel right now... I remember when Thor got hit by the Destroyer and rolled around on the ground, Loki was thrilled but Odin was crying. I don't know if IXHL can be compared to Thor, but won't this company find its original value? Personally, I think that $1, $2, $5, etc. are all gimmicks. NFA. $KLTO $DRUG $SLNO $AMAM $IMGN $REGN $NVAX $VKTX $PFE $LLY $RMD $INSP $PHG
0 · Reply
InLongtoRetire
InLongtoRetire Jun. 6 at 7:16 PM
$RMD Almost time to acquire RemSleep Holdings.
0 · Reply
Bongasaurus
Bongasaurus Jun. 6 at 12:49 PM
$RMD go the fk back down haha. My 250ps gotta print!
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:53 PM
$RMD plummeting at close $SPY $QQQ
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:32 PM
$RMD
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:11 PM
$RMD kill it! $SPY
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 6:18 PM
$RMD breaking down BIG time.. sub $250 soon. @SPY @QQQ
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 3:45 PM
$RMD short til $148 IMO $SPY $QQQ
0 · Reply
Doozio
Doozio Jun. 4 at 12:48 PM
$RMD out of 🐑⏰♾️ find the eps gap n goes on 4/24 above the 200d then it’s all chop chop huckleberries n PEGA da greed during 🐒🍌🧠⏰♾️
0 · Reply
DRex99
DRex99 May. 29 at 9:15 PM
$RMSL If Tom’s product is as good as he says it is you have to assume the big dogs are going to step in. If I’m $RMD or any major player I’m doing everything I can to slow him down. You have to assume there is going to be a fight. Competitors don’t just give up market share. Eyes open.
2 · Reply
SwingTradingPro
SwingTradingPro May. 28 at 11:59 AM
$IXHL company seems to be quite confident about phase 2 data and committed to preserve and improve shareholders value.. BO is coming sooner than later... $RMD
0 · Reply